{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T10:04:04Z","timestamp":1792317844546,"version":"4.4.0"},"reference-count":71,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Cardiovascular Medicine"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.tcm.2017.12.006","type":"journal-article","created":{"date-parts":[[2017,12,21]],"date-time":"2017-12-21T13:33:15Z","timestamp":1513863195000},"page":"330-337","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["ACE inhibition to slow progression of myocardial fibrosis in muscular dystrophies"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9227-0360","authenticated-orcid":false,"given":"Vincenzo","family":"Russo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea Antonio","family":"Papa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel Ato","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Rago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Palladino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Politano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerardo","family":"Nigro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tcm.2017.12.006_bib1","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/00019052-200310000-00003","article-title":"Cardiomyopathy in muscular dystrophies","volume":"16","author":"Muntoni","year":"2003","journal-title":"Curr Opin Neurol."},{"key":"10.1016\/j.tcm.2017.12.006_bib2","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1161\/CIRCIMAGING.110.960740","article-title":"Cardiac involvement in patients with muscular dystrophies: magnetic resonance imaging phenotype and genotypic considerations","volume":"4","author":"Verhaert","year":"2011","journal-title":"Circ Cardiovasc Imaging."},{"key":"10.1016\/j.tcm.2017.12.006_bib3","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.ahj.2008.01.018","article-title":"Characteristics and outcomes of cardiomyopathy in children with Duchenne or Becker muscular dystrophy: a comparative study from the Pediatric Cardiomyopathy Registry","volume":"155","author":"Connuck","year":"2008","journal-title":"Am Heart J"},{"key":"10.1016\/j.tcm.2017.12.006_bib4","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1016\/j.hrthm.2012.06.038","article-title":"Arrhythmias in the muscular dystrophies","volume":"9","author":"Groh","year":"2012","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.tcm.2017.12.006_bib5","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1001\/jama.1995.03520420066040","article-title":"Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure","volume":"273","author":"Garg","year":"1995","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.tcm.2017.12.006_bib6","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","article-title":"ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"62","author":"Yancy","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2017.12.006_bib7","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1161\/01.CIR.100.16.1734","article-title":"Progressive cardiac dysfunction and fibrosis in the cardiomyopathic hamster and effects of growth hormone and angiotensin-converting enzyme inhibition","volume":"100","author":"Ryoke","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.tcm.2017.12.006_bib8","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1161\/01.RES.68.5.1302","article-title":"Effects of quinapril, a new angiotensin converting enzyme inhibitor, on left ventricular failure and survival in the cardiomyopathic hamster. Hemodynamic, morphological, and biochemical correlates","volume":"68","author":"Haleen","year":"1991","journal-title":"Circ Res"},{"key":"10.1016\/j.tcm.2017.12.006_bib9","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1365-2796.2008.01981.x","article-title":"Renin\u2013angiotensin system revisited","volume":"264","author":"Saijonmaa","year":"2008","journal-title":"J Intern Med"},{"key":"10.1016\/j.tcm.2017.12.006_bib10","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00018-013-1349-6","article-title":"The pathogenesis of cardiac fibrosis","volume":"71","author":"Kong","year":"2014","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.tcm.2017.12.006_bib11","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.jacc.2015.06.1313","article-title":"Cardiac fibrosis in patients with atrial fibrillation: mechanisms and clinical implications","volume":"66","author":"Dzeshka","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2017.12.006_bib12","doi-asserted-by":"crossref","first-page":"C82","DOI":"10.1152\/ajpcell.00287.2006","article-title":"Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system","volume":"292","author":"Mehta","year":"2007","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.tcm.2017.12.006_bib13","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/S0735-1097(01)01518-2","article-title":"Effects of combination of angiotensin-converting enzyme inhibitor and angiotensin receptor antagonist on inflammatory cellular infiltration and myocardial interstitial fibrosis after acute myocardial infarction","volume":"38","author":"Yu","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2017.12.006_bib14","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1097\/FJC.0b013e318207a35f","article-title":"Fibrosis and cardiac arrhythmias","volume":"57","author":"de Jong","year":"2011","journal-title":"J Cardiovasc Pharmacol."},{"key":"10.1016\/j.tcm.2017.12.006_bib15","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1172\/JCI119360","article-title":"Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure: role of kinins and angiotensin II type 2 receptors","volume":"99","author":"Liu","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.tcm.2017.12.006_bib16","doi-asserted-by":"crossref","first-page":"4002","DOI":"10.1161\/01.CIR.96.11.4002","article-title":"Effect of angiotensin-converting enzyme inhibition on myocardial fibrosis and function in hypertrophied and failing myocardium from the spontaneously hypertensive rat","volume":"96","author":"Brooks","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.tcm.2017.12.006_bib17","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/S0735-1097(01)01518-2","article-title":"Effects of combination of angiotensin-converting enzyme inhibitor and angiotensin receptor antagonist on inflammatory cellular infiltration and myocardial interstitial fibrosis after acute myocardial infarction","volume":"38","author":"Yu","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2017.12.006_bib18","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1161\/01.CIR.91.5.1450","article-title":"Increased serum concentrations of procollagen peptides in essential hypertension relation to cardiac alterations","volume":"91","author":"D\u00edez","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.tcm.2017.12.006_bib19","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1161\/01.CIR.102.12.1388","article-title":"Lisinopril-mediated regression of myocardial fibrosis in patients with hypertensive heart disease","volume":"102","author":"Brilla","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.tcm.2017.12.006_bib20","first-page":"2436","article-title":"Angiotensin-converting enzyme inhibitors: a new mechanism of action","volume":"112","author":"Peng","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.tcm.2017.12.006_bib21","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0167-5273(90)90082-G","article-title":"The incidence and evolution of cardiomyopathy in Duchenne muscular dystrophy","volume":"26","author":"Nigro","year":"1990","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.tcm.2017.12.006_bib22","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1080\/21678707.2016.1234373","article-title":"Managing dystrophinopathic cardiomyopathy","volume":"4","author":"Politano","year":"2016","journal-title":"Expert Opin Orphan Drugs"},{"key":"10.1016\/j.tcm.2017.12.006_bib23","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1136\/hrt.2005.082909","article-title":"Is heart rate variability a valid parameter to predict sudden death in patients with Becker\u2019s muscular dystrophy?","volume":"92","author":"Ammendola","year":"2006","journal-title":"Heart"},{"key":"10.1016\/j.tcm.2017.12.006_bib24","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.jacc.2004.09.078","article-title":"Effect of perindopril on the onset and progression of left ventricular dysfunction in Duchenne muscular dystrophy","volume":"45","author":"Duboc","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2017.12.006_bib25","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.ahj.2007.05.014","article-title":"Perindopril preventive treatment on mortality in Duchenne muscular dystrophy: 10 years\u2019 follow-up","volume":"154","author":"Duboc","year":"2007","journal-title":"Am Heart J"},{"key":"10.1016\/j.tcm.2017.12.006_bib26","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.phrs.2011.06.002","article-title":"Enalapril treatment discloses an early role of angiotensin II in inflammation and oxidative stress-related muscle damage in dystrophic mdx mice","volume":"64","author":"Cozzoli","year":"2011","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.tcm.2017.12.006_bib27","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.amjcard.2006.04.020","article-title":"Left ventricular function and response to enalapril in patients with Duchenne muscular dystrophy during the second decade of life","volume":"98","author":"Ramaciotti","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.tcm.2017.12.006_bib28","doi-asserted-by":"crossref","first-page":"184","DOI":"10.4070\/kcj.2012.42.3.184","article-title":"The effect of enalapril and carvedilol on left ventricular dysfunction in middle childhood and adolescent patients with muscular dystrophy","volume":"42","author":"Kwon","year":"2012","journal-title":"Korean Circ J"},{"key":"10.1016\/j.tcm.2017.12.006_bib29","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1161\/CIRCULATIONAHA.104.528281","article-title":"Genetic predictors and remodeling of dilated cardiomyopathy in muscular dystrophy","volume":"112","author":"Jefferies","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.tcm.2017.12.006_bib30","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1001\/jamacardio.2016.4801","article-title":"Myocardial fibrosis progression in Duchenne and Becker muscular dystrophy: a randomized clinical trial","volume":"2","author":"Silva","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.tcm.2017.12.006_bib31","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1161\/CIRCULATIONAHA.111.031716","article-title":"Early treatment with lisinopril and spironolactone preserves cardiac and skeletal muscle in Duchenne muscular dystrophy mice","volume":"124","author":"Rafael-Fortney","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.tcm.2017.12.006_bib32","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.amjcard.2012.02.064","article-title":"Effects of angiotensin-converting enzyme inhibitors and\/or beta blockers on the cardiomyopathy in Duchenne muscular dystrophy","volume":"110","author":"Viollet","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.tcm.2017.12.006_bib33","article-title":"A randomized, double-blind trial of lisinopril and losartan for the treatment of cardiomyopathy in Duchenne muscular dystrophy","volume":"5","author":"Allen","year":"2013","journal-title":"PLoS Curr"},{"key":"10.1016\/j.tcm.2017.12.006_bib34","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.tcm.2016.02.008","article-title":"New medications for heart failure","volume":"26","author":"Gordin","year":"2016","journal-title":"Trends Cardiovasc Med."},{"key":"10.1016\/j.tcm.2017.12.006_bib35","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1161\/CIR.0000000000000526","volume":"136","author":"Feingold","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.tcm.2017.12.006_bib36","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/s12265-015-9623-7","article-title":"Absence of cardiac benefit with early combination ACE inhibitor and beta blocker treatment in mdx mice","volume":"8","author":"Blain","year":"2015","journal-title":"J Cardiovasc Transl Res."},{"key":"10.1016\/j.tcm.2017.12.006_bib37","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1253\/circj.70.991","article-title":"Beta-blocker therapy for cardiac dysfunction in patients with muscular dystrophy","volume":"70","author":"Kajimoto","year":"2006","journal-title":"Circ J"},{"key":"10.1016\/j.tcm.2017.12.006_bib38","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jjcc.2008.08.013","article-title":"Beneficial effects of beta-blockers and angiotensin-converting enzyme inhibitors in Duchenne muscular dystrophy","volume":"53","author":"Ogata","year":"2009","journal-title":"J Cardiol"},{"key":"10.1016\/j.tcm.2017.12.006_bib39","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/mus.23808","volume":"48","author":"Henricson","year":"2013","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.tcm.2017.12.006_bib40","first-page":"98","article-title":"Beneficial effects of angiotensin-converting-enzyme (ACE) inhibitors in Dystrophinopathic cardiomyopathy","volume":"29","author":"Politano","year":"2010","journal-title":"Acta Miol"},{"key":"10.1016\/j.tcm.2017.12.006_bib41","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1532-429X-13-60","article-title":"Effects of steroids and angiotensin converting enzyme inhibition on circumferential strain in boys with Duchenne muscular dystrophy: a cross-sectional and longitudinal study utilizing cardiovascular magnetic resonance","volume":"13","author":"Hor","year":"2011","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.tcm.2017.12.006_bib42","first-page":"110","article-title":"The heart and cardiac pacing in Steinert disease","volume":"31","author":"Nigro","year":"2012","journal-title":"Acta Myol"},{"key":"10.1016\/j.tcm.2017.12.006_bib43","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1093\/oxfordjournals.eurheartj.a061011","article-title":"Cardiac involvement in patients with myotonic dystrophy: characteristic features of magnetic resonance imaging","volume":"16","author":"De Ambroggi","year":"1995","journal-title":"Eur Heart J"},{"key":"10.1016\/j.tcm.2017.12.006_bib44","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1016\/j.hrthm.2012.06.032","article-title":"Assessment of cardiac involvement in myotonic muscular dystrophy by T1 mapping on magnetic resonance imaging","volume":"9","author":"Turkbey","year":"2012","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.tcm.2017.12.006_bib45","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/jce.12821","article-title":"The role of the atrial electromechanical delay in predicting atrial fibrillation in myotonic dystrophy type 1 patients","volume":"27","author":"Russo","year":"2016","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.tcm.2017.12.006_bib46","first-page":"1241","article-title":"Paroxysmal atrial fibrillation in myotonic dystrophy type 1 patients: P wave duration and dispersion analysis","volume":"19","author":"Russo","year":"2015","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.tcm.2017.12.006_bib47","first-page":"3991","article-title":"Atrial electromechanical delay in myotonic dystrophy type 1 patients","volume":"19","author":"Russo","year":"2015","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.tcm.2017.12.006_bib48","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1111\/j.1540-8159.2008.01210.x","article-title":"Optimal site for atrial lead implantation in myotonic dystrophy patients: the role of Bachmann\u2019s bundle stimulation","volume":"31","author":"Nigro","year":"2008","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.tcm.2017.12.006_bib49","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1111\/j.1540-8159.2009.02464.x","article-title":"Right atrial appendage versus Bachmann\u2019s bundle stimulation: a two-year comparative study of electrical parameters in myotonic dystrophy type-1 patients","volume":"32","author":"Nigro","year":"2009","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.tcm.2017.12.006_bib50","first-page":"94","article-title":"Far field R-wave sensing in myotonic dystrophy type 1: right atrial appendage versus Bachmann\u2019s bundle region lead placement","volume":"33","author":"Russo","year":"2014","journal-title":"Acta Myol"},{"key":"10.1016\/j.tcm.2017.12.006_bib51","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1093\/europace\/euq170","article-title":"Does Bachmann\u2019s bundle pacing prevent atrial fibrillation in myotonic dystrophy type 1 patients? A 12 months follow-up study","volume":"12","author":"Nigro","year":"2010","journal-title":"Europace"},{"key":"10.1016\/j.tcm.2017.12.006_bib52","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.5603\/KP.2013.0295","article-title":"Does a high percentage of right ventricular pacing influence the incidence of paroxysmal atrial in myotonic dystrophy type 1 patients?","volume":"71","author":"Russo","year":"2013","journal-title":"Kardiol Pol"},{"key":"10.1016\/j.tcm.2017.12.006_bib53","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1093\/europace\/eur373","article-title":"The effect of atrial preference pacing on paroxysmal atrial fibrillation incidence in myotonic dystrophy type 1 patients: a prospective, randomized, single-bind cross-over study","volume":"14","author":"Russo","year":"2012","journal-title":"Europace"},{"key":"10.1016\/j.tcm.2017.12.006_bib54","first-page":"139","article-title":"Right atrial preference pacing algorithm in the prevention of paroxysmal atrial fibrillation in myotonic dystrophy type 1 patients: a long term follow-up study","volume":"31","author":"Nigro","year":"2012","journal-title":"Acta Myol"},{"key":"10.1016\/j.tcm.2017.12.006_bib55","first-page":"142","article-title":"Atrial fibrillation burden in myotonic dystrophy type 1 patients implanted with dual chamber pacemaker: the efficacy of the overdrive atrial algorithm at 2 year follow-up","volume":"32","author":"Russo","year":"2013","journal-title":"Acta Myol"},{"key":"10.1016\/j.tcm.2017.12.006_bib56","first-page":"127","article-title":"The effect of atrial preference pacing on atrial fibrillation electrophysiological substrate in myotonic dystrophy type 1 population","volume":"33","author":"Russo","year":"2014","journal-title":"Acta Myol"},{"key":"10.1016\/j.tcm.2017.12.006_bib57","first-page":"149","article-title":"Ventricular fibrillation induced by coagulating mode bipolar electrocautery during pacemaker implantation in myotonic dystrophy type 1 patient","volume":"33","author":"Russo","year":"2014","journal-title":"Acta Myol"},{"key":"10.1016\/j.tcm.2017.12.006_bib58","first-page":"100","article-title":"Increased heterogeneity of ventricular repolarization in myotonic dystrophy type 1 population","volume":"35","author":"Russo","year":"2016","journal-title":"Acta Myol"},{"key":"10.1016\/j.tcm.2017.12.006_bib59","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.ijcard.2016.01.175","article-title":"Sudden cardiac death in neuromuscolar disorders: time to establish shared protocols for cardiac pacing","volume":"207","author":"Russo","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.tcm.2017.12.006_bib60","first-page":"517","article-title":"Early onset \u201celectrical\u201d heart failure in myotonic dystrophy type 1 patient: the role of ICD biventricular pacing","volume":"12","author":"Russo","year":"2012","journal-title":"Anadolu Kardiyol Derg"},{"key":"10.1016\/j.tcm.2017.12.006_bib61","first-page":"154","article-title":"Cardiac resynchronization improves heart failure in one patient with myotonic dystrophy type 1. A case report","volume":"31","author":"Russo","year":"2012","journal-title":"Acta Myol"},{"key":"10.1016\/j.tcm.2017.12.006_bib62","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/6799","article-title":"Mutations in the gene encoding lamin A\/C cause autosomal dominant Emery\u2013Dreifuss muscular dystrophy","volume":"21","author":"Bonne","year":"1999","journal-title":"Nat Genet"},{"key":"10.1016\/j.tcm.2017.12.006_bib63","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1136\/hrt.82.1.105","article-title":"Cardiac involvement in Emery\u2013Dreifuss muscular dystrophy: a case series","volume":"82","author":"Buckley","year":"1999","journal-title":"Heart"},{"key":"10.1016\/j.tcm.2017.12.006_bib64","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.2310\/JIM.0b013e31822cf97a","article-title":"P wave duration and dispersion in Emery\u2013Dreifuss muscolar distrophy","volume":"59","author":"Russo","year":"2011","journal-title":"J Investigat Med"},{"key":"10.1016\/j.tcm.2017.12.006_bib65","doi-asserted-by":"crossref","first-page":"CR643","DOI":"10.12659\/MSM.883541","article-title":"Increased dispersion of ventricular repolarization in Emery\u2013Dreifuss muscular dystrophy patients","volume":"18","author":"Russo","year":"2012","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.tcm.2017.12.006_bib66","first-page":"1154","article-title":"Regional and transmural dispersion of repolarisation in patients with Emery\u2013Dreifuss muscular dystrophy","volume":"70","author":"Nigro","year":"2012","journal-title":"Kardiol Pol"},{"key":"10.1016\/j.tcm.2017.12.006_bib67","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1093\/europace\/euu146","article-title":"ICD role in preventing sudden cardiac death in Emery\u2013Dreifuss muscular dystrophy with preserved myocardial function: 2013 ESC Guidelines on Cardiac Pacing and Cardiac Resynchronization Therapy","volume":"17","author":"Russo","year":"2015","journal-title":"Europace"},{"key":"10.1016\/j.tcm.2017.12.006_bib68","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.nmd.2009.12.004","article-title":"Early onset of cardiomyopathy and primary prevention of sudden death in X-linked Emery\u2013Dreifuss muscular dystrophy","volume":"20","author":"Nigro","year":"2010","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.tcm.2017.12.006_bib69","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1080\/10976640600723862","article-title":"Primary myocardial dysfunction in autosomal dominant EDMD. A tissue doppler and cardiovascular magnetic resonance study","volume":"8","author":"Smith","year":"2006","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.tcm.2017.12.006_bib70","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1093\/hmg\/ddt514","article-title":"Restoration of muscle strength in dystrophic muscle by angiotensin-1-7 through inhibition of TGF-\u03b2 signalling","volume":"23","author":"Acu\u00f1a","year":"2014","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.tcm.2017.12.006_bib71","doi-asserted-by":"crossref","first-page":"e93449","DOI":"10.1371\/journal.pone.0093449","article-title":"ACE2 Is augmented in dystrophic skeletal muscle and plays a role in decreasing associated fibrosis","volume":"9","author":"Riquelme","year":"2014","journal-title":"PLoS ONE"}],"container-title":["Trends in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1050173817301949?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1050173817301949?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,14]],"date-time":"2018-08-14T11:42:36Z","timestamp":1534246956000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1050173817301949"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":71,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S1050173817301949"],"URL":"https:\/\/doi.org\/10.1016\/j.tcm.2017.12.006","relation":{},"ISSN":["1050-1738"],"issn-type":[{"value":"1050-1738","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ACE inhibition to slow progression of myocardial fibrosis in muscular dystrophies","name":"articletitle","label":"Article Title"},{"value":"Trends in Cardiovascular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tcm.2017.12.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}